ESC Professional Premium Access

Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis.

Congress Presentation

About the speaker

Doctor Tommaso Bucci

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Duration of left and right atrial activation wavefront assessed non-invasively is significantly higher in patients with atrial fibrillation than in controls.

Speaker: Doctor L. Parreira (Setubal, PT)

Thumbnail

The risk and cause of death according to prevalent atrial fibrillation and the role of CHA2DS2-VASc score to stratify the risk of all-cause and cardiovascular death

Speaker: Doctor Y. Kim (Seoul, KR)

Thumbnail

Lower risk of atrial fibrillation development associated with SGLT-2 inhibitors in type 2 diabetic patients compared to DPP-4 inhibitors: a nationwide cohort study

Speaker: Doctor J. Lee (Cheongju, KR)

Thumbnail

Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry

Speaker: Doctor D. Morrone (Pisa, IT)

Thumbnail

Impact of atrial fibrillation burden on longitudinal changes in left ventricular structure and function: a post-hoc analysis of a randomized clinical trial

Speaker: Miss F. Vyff (Gentofte, DK)

Thumbnail

Access the full session

Remodelling, prognosis, and outcomes in atrial fibrillation

Speakers: Doctor T. Bucci, Doctor L. Parreira, Doctor Y. Kim, Doctor J. Lee, Doctor D. Morrone...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by